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ABSTRACT
Lymphogranuloma venereum (LGV) is a rare form of the sexually transmitted disease caused by
Chlamydia trachomatis. In the United States, there are fewer than 350 cases per year. In a review
of the world’s literature, there has not been a case reported in the last thirty years of a case ofLGV
presenting as a rectovaginal fistula. We present a case of an otherwise healthy American woman
who presented with a rectovaginal fistula. Although uncommon, LGV does occur in developed
countries and may have devastating tissue destruction if not recognized and treated before the
tertiary stage. Infect. Dis. Obstet. Gynecol. 7:199-201, 1999. (C) 1999 Wiley-Liss, Inc.
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INTRODUCTION
Lymphogranuloma venereum (LGV) has a re-
ported incidence of approximately 350 cases per
year in the United States and rarely presents in its
tertiary or anorectogenital stage. We present a case
of a woman with a rectovaginal fistula due to LGV.
CASE REPORT
A 43-year old black female, gravida 2 para 2, pre-
sented with a 2-month history of passing stool
through her vagina. She also noted increasing vul-
var swelling and discomfort over the last several
months. She stated that approximately three years
ago she had a swollen right lymph node in the groin
region, which was surgically drained and then re-
solved. An edematous process began again approxi-
mately 6 months ago, which now included her en-
tire vulva. She had no significant past medical his-
tory. Her past surgical history was significant only
for a nonmalignant right breast biopsy for a non-
tender mass. She had a history of normal monthly
periods at regular intervals and denied a history of
sexually transmitted diseases or abnormal pap
tests. She was married and stated that she had been
monogamous for six years. There was no significant
family history. The patient smoked one pack per
day for 25 years and drank one liter of alcohol per
week. She denied illicit drug use. Physical exami-
nation revealed an afebrile 5’4", 132-1b. woman
with blood pressure of 106/48. General physical
exam and mental status exam were normal. No
skin abnormalities were noted with the exception
of the pelvic findings. The pelvic exam revealed
enlarged, irregular, edematous labia, bilaterally,
with complete distortion of the right labia majora
due to edema and fecal soiling (Fig. 1). Tissue
bridges and draining sinuses were visually noted as
well as a rectovaginal fistula and several blind tracts
(Fig. 2). An internal examination was unable to be
performed secondary to pain. Consultations with
specialists from gynecologic oncology, colorectal
surgery, and infectious disease were obtained. Af-
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Fig. I. Vulva and perineum. Right labia with distortion
from lymphedema.
ter consultation the differential diagnosis included
hidradenitis suppurativa, LGV, and vulvar or rectal
cancer.
Biopsies and a wound culture as well as titers for
Chlamydia, Nocardia, and acid-fast bacilli were
taken. The patient was empirically started on
doxycycline 100 mg p.o. twice a day due to the
likelihood of infectious etiology. Serology was posi-
tive only for Chlamydia by complement fixation (ti-
ter at 1:8 with reference range <1:8). Biopsy
showed benign squamous epithelium with submu-
cosal chronic inflammation.
A colostomy was performed one week after ini-
tial evaluation along with an examination under
anesthesia. There were visible draining sinuses in
the perirectal area. Proctoscopy examination re-
vealed involvement of anal margin but did not ex-
tend beyond the anal verge. A large LGV lesion
was visible. The area was erythematous and
edematous with pocking, and there were several
sinus tracts in the involved area. The rest of the
anal canal was essentially normal.
The patient did well postoperatively, with the
exception of a complaint of yellow-green vaginal
discharge six weeks postoperatively. Wet prep
evaluation revealed Trichomonas that was treated
with metronidazole.
Seventeen weeks after the first surgery, the pa-
tient underwent a partial vulvectomy, repair of rec-
tovaginal fistula, and debridement of the remain-
der of the affected perineum. One week later, a
split-thickness skin grafting to the debrided area
was performed.
Three months later, the patient underwent clo-
sure of the colostomy after the skin graft had
healed. At this time, there was no evidence of fis-
tula in the rectum or vagina.
DISCUSSION
LGV is rare in North America with fewer than 350
cases per year in the United States. The causative
organism for LGV is Chlamydia trachomatis sero-
types L1, L2, and L3. The incubation can last from
a few days to 21 days. The primary lesion of this
disease is a painless ulcer, which often goes unno-
ticed and resolves spontaneously. In the following
weeks, the secondary stage presents as a painful
lymphadenopathy in the inguinal lymph nodes de-
velops. In the absence of treatment, the overlying
skin becomes brawny and wrinkled with a charac-
teristic violaceous hue, and the abscesses within
the nodes coalesce and drain from one or more
sinus tracts. The tertiary stage involves perirectal
abscesses and rectal strictures and fistulas. This
stage is usually seen in women and homosexual
men. The patient usually has a mild leukocytosis
with an elevation in monocytes and eosinophils, z
LGV can be diagnosed though serologic detection
of antibodies to C. trachomatis, complement fixa-
tion, DNA probe, lymph node culture, or physical
examination.3 Due to the lack of specificity and
sensitivity of the serologic test for Chlamydia spe-
cies, a thorough physical exam often confirms the
diagnosis.
In this patient, the differential diagnosis in-
cluded hidradenitis suppurativa, and rectal or vul-
var carcinoma. The vulvar biopsy in our patient,
however, revealed edematous tissue that was not
purulent or sebaceous in character. Since she also
had a positive Chlamydia-specific antibody test, a
diagnosis of the tertiary stage of LGV was made.
Treatment of LGV includes a three-week
course of a tetracycline or erythromycin (or azithro-
mycin), 500 mg four times a day.4 Sulfadiazine may
be useful and is administered by giving a loading
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Fig. 2. Operator’s fingertip visible through rectovaginal fistula. Multiple sinus tracts visible.
dose of 2 g followed by 4 g a day for 10-28 days.
Erythromycin or azithromycin would be indicated
in pregnancy. In this case, a six-week course was
given because of tissue induration and suspected
poor perfusion with gross fecal contamination. The
LGV lesion improved with doxycycline, but the
extensive involvement of the perineum mandated
surgical as well as medical therapy. Follow-up care
was needed to repair the damage caused by the
lymphedema. Surgical debridement is recom-
mended in this type of presentation.5
Although LGV is rare is the United States in
1988, Epling and Reich reported an outbreak of
LGV in Central Florida linked with prostitution.6
In fact, two months after this presentation, a sec-
ond woman came to this clinic with a case of sec-
ondary LGV. Although, LGV is a rare disease in
this country, it can be carried due to global travel,
migration, and immigration. Because this disease
starts as a painless ulcer and resolves rather
quickly, it is often ignored in the primary stage.
Because of this seemingly harmless first stage, this
disease can be transmitted unknowingly to other
people.
7 Although it is rare in developed countries,
all clinicians should be mindful of this entity in
order to prevent the spread and the destructive
tertiary stage of this disease.
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